Steven Bariahtaris
Directeur Financier/CFO chez Liquidia Technologies, Inc.
Fortune : - $ au 30/04/2024
Profil
Steven Bariahtaris is currently the Chief Financial Officer at Liquidia Technologies, Inc. He previously worked as an Independent Director at Carmell Corp.
and as the Chief Audit Executive & Worldwide Vice President at Johnson & Johnson Services, Inc. He also briefly served as the Chief Financial Officer at Liquidia Corp.
Mr. Bariahtaris received his undergraduate degree from Cornell University and his MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
14/07/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Steven Bariahtaris
Sociétés | Poste | Début |
---|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Directeur Financier/CFO | 20/08/2020 |
Anciens postes connus de Steven Bariahtaris
Sociétés | Poste | Fin |
---|---|---|
CARMELL CORPORATION | Directeur/Membre du Conseil | 31/08/2023 |
LIQUIDIA CORPORATION | Directeur Financier/CFO | 30/11/2020 |
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Part of Johnson & Johnson, Johnson & Johnson Services, Inc. provides home and health care services. The company is based in New Brunswick, NJ and was founded in 1886. | Directeur Financier/CFO | - |
Formation de Steven Bariahtaris
Cornell University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
LIQUIDIA CORPORATION | Health Technology |
CARMELL CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Part of Johnson & Johnson, Johnson & Johnson Services, Inc. provides home and health care services. The company is based in New Brunswick, NJ and was founded in 1886. | Health Technology |